Study | AgNP source | Target bacteria | Concentration/method | Antibacterial activity |
---|---|---|---|---|
Ray et al. | Gossypium hirsutum | Xanthomonas campestris | Not specified | Effective (no measurement) |
Ray et al. | Gossypium hirsutum | X. axonopodis | Not specified | Effective (no measurement) |
Lava et al. | Justica wynaadensis | Escherichia coli | 600 µg/mL | 14 mm inhibition zone |
Lava et al. | Justica wynaadensis | Micrococcus luteus | 800 µg/mL | 15 mm inhibition zone |
Current study | Psidium guajava | Staphylococcus aureus | CFU reduction method | 87.8% population reduction (AgNPs) |
Current study | Psidium guajava (AgNP/S18 nanocomposite) | Staphylococcus aureus | CFU reduction method | 72% population reduction |